Literature DB >> 29189836

Practical synthesis of pharmaceutically relevant molecules enriched in sp3 character.

Peter S Campbell1, Craig Jamieson, Iain Simpson, Allan J B Watson.   

Abstract

The expedient synthesis of compounds enriched in sp3 character is key goal in modern drug discovery. Herein, we report how a single pot Suzuki-Miyaura-hydrogenation can be used to furnish lead and fragment-like products in good to excellent yields. The approach has been successfully applied in formats amenable to parallel synthesis, in an asymmetric sense, and in the preparation of molecules with annotated biological activity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29189836     DOI: 10.1039/c7cc08670a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Expanding the medicinal chemistry synthetic toolbox.

Authors:  Jonas Boström; Dean G Brown; Robert J Young; György M Keserü
Journal:  Nat Rev Drug Discov       Date:  2018-08-24       Impact factor: 84.694

2.  Visible-Light-Promoted Iron-Catalyzed C(sp2 )-C(sp3 ) Kumada Cross-Coupling in Flow.

Authors:  Xiao-Jing Wei; Irini Abdiaj; Carlo Sambiagio; Chenfei Li; Eli Zysman-Colman; Jesús Alcázar; Timothy Noël
Journal:  Angew Chem Int Ed Engl       Date:  2019-07-11       Impact factor: 15.336

3.  Structural Similarities between Some Common Fluorophores Used in Biology, Marketed Drugs, Endogenous Metabolites, and Natural Products.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  Mar Drugs       Date:  2020-11-23       Impact factor: 5.118

4.  One-Pot Suzuki-Hydrogenolysis Protocol for the Modular Synthesis of 2,5-Diaryltetrazoles.

Authors:  Keith Livingstone; Sophie Bertrand; Craig Jamieson
Journal:  J Org Chem       Date:  2020-05-21       Impact factor: 4.354

5.  Merging Halogen-Atom Transfer (XAT) and Copper Catalysis for the Modular Suzuki-Miyaura-Type Cross-Coupling of Alkyl Iodides and Organoborons.

Authors:  Zhenhua Zhang; Bartosz Górski; Daniele Leonori
Journal:  J Am Chem Soc       Date:  2022-01-21       Impact factor: 16.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.